or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 Commission File Number: 000-09908 TOMI ENVIRONMENTAL SOLUTIONS, INC. (Exact name of registrant as specified in its charter) (State or other juri ...

TOMI Environmental Solutions, Inc. (NASDAQ:TOMZ) Q1 2021 Results Conference Call May 17, 2021 4:30 PM ET Company Participants John Nesbett - IMS Investor Relations Dr. Halden Shane - Chairman and CEO Nick Jennings - CFO Operator Good day, ladies and gentlemen, and welcome to the TOMI Environmental Solutions Inc., First Quarter 2021 Financial Results Conference Call. At this time, all participants have been placed on a listen-only mode and the floor will be opened for questions and comments after the present ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 000-09908 TOMI ENVIRONMENTAL SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Florida 59-1947988 ...

Financial Data and Key Metrics Changes - In 2020, the company achieved record revenues of $25 million, a significant increase of 297% compared to $6.3 million in 2019 [7][19] - Net profit for 2020 was $4.4 million, or $0.23 per diluted share, compared to a net loss of $2.3 million in the previous year [7][20] - Adjusted EBITDA for 2020 was $8.4 million, with an adjusted EBITDA margin of 33%, compared to an adjusted EBITDA loss of $1.2 million in 2019 [20] - For Q4 2020, total net revenue was $3.7 million, up 95% from $1.9 million in Q4 2019 [21] - Gross margins for 2020 were 60.1%, slightly down from 61.7% in 2019, attributed to product mix [20] Business Line Data and Key Metrics Changes - The healthcare division saw significant purchases, including multiple units by various healthcare systems, indicating strong demand for SteraMist products [26][30] - The life sciences division maintained strong performance, with SteraMist being implemented in pharmaceutical manufacturing and COVID-19 vaccine production [38] - The commercial division expanded its customer base, including emergency services and educational institutions, highlighting the versatility of SteraMist applications [51][56] Market Data and Key Metrics Changes - The COVID-19 pandemic has heightened the demand for disinfection solutions, leading to increased sales and brand recognition for SteraMist [12][66] - The company plans to expand its international presence, establishing service centers in Europe and Southeast Asia to capture global market opportunities [80] Company Strategy and Development Direction - The company is focused on long-term growth rather than short-term performance, aiming to establish SteraMist as the industry standard for disinfection [14][67] - Plans for 2021 include launching multiple new products and targeting a revenue growth of 40% to 45% compared to 2020 [15][68] - The company is investing in R&D to enhance its technology and expand its product offerings, including the development of the SteraBot and SteraPack [76][69] Management's Comments on Operating Environment and Future Outlook - Management emphasized the importance of preparedness for future pandemics and the ongoing demand for effective disinfection solutions [63][64] - The company is optimistic about continued growth in market share and brand awareness, supported by a strong customer referral network [68][70] Other Important Information - The company has filed for new IP protections to secure its technology and is actively pursuing opportunities in the food safety industry [9][46] - SteraMist technology has been recognized for its effectiveness against various pathogens, including MRSA and COVID-19, positioning the company as a leader in the disinfection market [11][66] Q&A Session Summary Question: Insights on the razor, razor blade model and margins - Management indicated that margins from SteraMist BIT solution sales are stronger than those from equipment sales, with expectations for solution revenue to increase as more machines are deployed [72][73] Question: Future R&D spending - Management plans to increase R&D spending to develop new applications and products, including the CES and SteraPack [76] Question: Pricing of the SteraPack and international expansion plans - The SteraPack is expected to be competitively priced around $6,000, and the company is actively working on expanding its international presence through service centers and product registrations [79][80]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-09908 TOMI ENVIRONMENTAL SOLUTIONS, INC. (Exact name of registrant as specified in its charter) FLORIDA 59-1947988 (State or other jurisdiction ...

TOMI Environmental Solutions, Inc. (NASDAQ:TOMZ) Q3 2020 Earnings Conference Call November 12, 2020 4:30 PM ET Company Participants Halden Shane - Chairman and CEO Nick Jennings - CFO Conference Call Participants Operator Thank you for joining us today for the TOMI Environmental Solutions Investor Update Conference Call. On today’s call is TOMI’s CEO and Chairman of the Board, Dr. Halden Shane, and Nick Jennings, TOMI’s CFO. Dr. Shane will provide an overview of recent business highlights and discuss critic ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or (800) 525-1698 (Registrant's telephone number, including area code) 9454 Wilshire Blvd., Penthouse, Beverly Hills, CA 90212 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 TOMI ENVIRONMENTAL SOLUTIONS, INC. FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 000-09908 (Exact name of registrant as specified in its charter) (State or other juri ...

TOMI Environmental Solutions, Inc. (NASDAQ:TOMZ) Q2 2020 Results Earnings Conference Call August 13, 2020 4:30 PM ET Company Participants Dr. Halden Shane - Chairman and CEO Nick Jennings - Chief Financial Officer Conference Call Participants Operator Thank you for joining us today for the TOMI Environmental Solutions Investor Update Conference Call. On today’s call is TOMI’s CEO and Chairman of the Board, Dr. Halden Shane, who will provide an overview of recent business highlights for the most recent quart ...

TOMI Environmental Solutions, Inc. (NASDAQ:TOMZ) Q1 2020 Earnings Conference Call May 18, 2020 4:30 PM ET Company Participants Halden Shane - Chairman and Chief Executive Officer Nick Jennings - Chief Financial Officer Conference Call Participants Operator Thank you for joining us today for TOMI's Environmental Solutions Investor Update Conference Call. On today's call is TOMI's CEO and Chairman of the Board, Dr. Halden Shane, who will provide an overview of recent business highlights for the most recent qu ...